Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Structure-Activity Relationships of Organofluorine Inhibitors of β-Amyloid Self-Assembly

  • Béla Török
  • , Abha Sood
  • , Seema Bag
  • , Aditya Kulkarni
  • , Dmitry Borkin
  • , Elizabeth Lawler
  • , Sujaya Dasgupta
  • , Shainaz Landge
  • , Mohammed Abid
  • , Weihong Zhou
  • , Michelle Foster
  • , Harry Levine
  • , Marianna Török

Producción científica: Articlerevisión exhaustiva

39 Citas (Scopus)

Resumen

A broad group of structurally diverse small organofluorine compounds were synthesized and evaluated as inhibitors of β-amyloid (Aβ) self-assembly. The main goal was to generate a diverse library of compounds with the same functional group and to observe general structural features that characterize inhibitors of Aβ oligomer and fibril formation, ultimately identifying structures for further focused inhibitor design. The common structural motifs in these compounds are CF 3-C-OH and CF 3-C-NH groups that were proposed to be binding units in our previous studies. A broad range of potential small-molecule inhibitors were synthesized by combining various carbocyclic and heteroaromatic rings with an array of substituents, generating a total of 106 molecules. The compounds were tested by standard methods such as thioflavin-T fluorescence spectroscopy for monitoring fibril formation, biotinyl Aβ 1-42 single-site streptavidin-based assays for observing oligomer formation, and atomic force microscopy for morphological studies. These assays revealed a number of structures that show significant inhibition against either Aβ fibril or oligomer formation. A detailed analysis of the structure-activity relationship of anti-fibril and -oligomer properties is provided. These data present further experimental evidence for the distinct nature of fibril versus oligomer formation and indicate that the interaction of the Aβ peptide with chiral small molecules is not stereospecific in nature.

Idioma originalEnglish
Páginas (desde-hasta)910-919
Número de páginas10
PublicaciónChemMedChem
Volumen7
N.º5
DOI
EstadoPublished - may 2012

Financiación

FinanciadoresNúmero del financiador
National Institute on AgingR21AG028816

    ASJC Scopus subject areas

    • Drug Discovery
    • General Pharmacology, Toxicology and Pharmaceutics
    • Molecular Medicine
    • Biochemistry
    • Pharmacology
    • Organic Chemistry

    Huella

    Profundice en los temas de investigación de 'Structure-Activity Relationships of Organofluorine Inhibitors of β-Amyloid Self-Assembly'. En conjunto forman una huella única.

    Citar esto